Gestalt Diagnostics: Algorithm for Use on Eight Types of Cancer Trained on Seven Scanner Models SPOKANE, Wash., Sept. 19, 2023 /PRNewswire/ -- Gestalt Diagnostics is proud to announce our latest release – an AI algorithm for use on one of...

Gestalt - Hamamatsu unified solution will provide end-to-end support to the entire workflow June 7, 2022 – Spokane, WA. Today, Gestalt Diagnostics, Inc., a leading provider of digital pathology solutions, and Hamamatsu Photonics K.K., a...

Proscia and Hamamatsu: Cooperation agreement expands access to unified solution for end-to-end workflow PHILADELPHIA – March 9, 2022 – Proscia®, the leader in digital and computational pathology solutions, and Hamamatsu Photonics K.K.,...

Albuquerque, NM, USA and Nottingham, UK, 1 July, 2021 – Following a formal tender process, Nottingham University Hospitals (NUH) NHS Trust today announced the selection of Indica Labs to aid in full digitisation of the pathology workflow....

Join Dr. Nguyen from University of Montreal Hospital Centre (CHUM) on May the 25th at 11am EST to hear about CHUM’s implementation process & benefits of digital pathology for routine diagnosis. Dr Nguyen is Professor of Pathology at...

Cancer informatics and digital pathology workflow solution provider Inspirata® Europe, Ltd. revealed it has entered into a partnership agreement with Hamamatsu Photonics affording shared customers with the ability to view native Hamamatsu...